潜在性結核感染（LTBI）テストの世界市場 2019年版：種類別（ツベルクリン皮膚試験（TST）、インターフェロンガンマ放出アッセイ（IGRA）、その他）、用途別（肺結核家庭内接触、PLHIV、その他）

• 英文タイトル：Global Latent Tuberculosis Infection (LTBI) Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：C-GIR20G2816
• 出版社/出版日：GlobalInfoResearch / 2019年12月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

「潜在性結核感染（LTBI）テストの世界市場2019年」は、グローバルにおける潜在性結核感染（LTBI）テスト市場を展望するレポートです。潜在性結核感染（LTBI）テストのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。
・潜在性結核感染（LTBI）テストの市場概観
・潜在性結核感染（LTBI）テストの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・潜在性結核感染（LTBI）テストの企業別販売動向、市場シェア、市場集中度、競争動向
・潜在性結核感染（LTBI）テストの世界市場規模
・潜在性結核感染（LTBI）テストの北米市場分析（アメリカ、カナダ、メキシコ等）
・潜在性結核感染（LTBI）テストのアメリカ市場規模推移
・潜在性結核感染（LTBI）テストのカナダ市場規模推移
・潜在性結核感染（LTBI）テストのメキシコ市場規模推移
・潜在性結核感染（LTBI）テストのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・潜在性結核感染（LTBI）テストのドイツ市場規模推移
・潜在性結核感染（LTBI）テストのイギリス市場規模推移
・潜在性結核感染（LTBI）テストのロシア市場規模推移
・潜在性結核感染（LTBI）テストのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・潜在性結核感染（LTBI）テストの日本市場規模推移
・潜在性結核感染（LTBI）テストの中国市場規模推移
・潜在性結核感染（LTBI）テストの韓国市場規模推移
・潜在性結核感染（LTBI）テストのインド市場規模推移
・潜在性結核感染（LTBI）テストの東南アジア市場規模推移
・潜在性結核感染（LTBI）テストの南米市場分析（ブラジル、アルゼンチン等）
・潜在性結核感染（LTBI）テストの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・潜在性結核感染（LTBI）テストの種類別分析/販売量、売上、市場シェア（ツベルクリン皮膚試験（TST）、インターフェロンガンマ放出アッセイ（IGRA）、その他）
・潜在性結核感染（LTBI）テストの用途別分析/市場規模（肺結核家庭内接触、PLHIV、その他）
・潜在性結核感染（LTBI）テストの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・潜在性結核感染（LTBI）テストの販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Latent Tuberculosis Infection (LTBI) Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Latent Tuberculosis Infection (LTBI) Testing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Latent Tuberculosis Infection (LTBI) Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Latent Tuberculosis Infection (LTBI) Testing market by product type and applications/end industries.

Market Segment by Companies, this report covers
Agilent Technologies
Bio-Rad Laboratories
Danaher
BioMerieux
Qiagen
Thermo Fisher Scientific
Abbott Laboratories
Becton Dickinson
Roche
Eppendorf

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Market Segment by Applications, can be divided into
Household Contacts with Pulmonary TB
PLHIV
Others

レポート目次

Table of Contents

1 Latent Tuberculosis Infection (LTBI) Testing Market Overview
1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Classification of Latent Tuberculosis Infection (LTBI) Testing by Types
1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Comparison by Types (2019-2024)
1.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Types in 2018
1.2.3 Tuberculin Skin Test (TST)
1.2.4 Interferon Gamma Released Assay (IGRA)
1.2.5 Others
1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
1.3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Household Contacts with Pulmonary TB
1.3.3 PLHIV
1.3.4 Others
1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Regions
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2014-2024)
1.5 Global Market Size of Latent Tuberculosis Infection (LTBI) Testing (2014-2024)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Business Overview
2.1.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bio-Rad Laboratories
2.2.1 Business Overview
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.3 Danaher
2.3.1 Business Overview
2.3.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Danaher Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.4 BioMerieux
2.4.1 Business Overview
2.4.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.5 Qiagen
2.5.1 Business Overview
2.5.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Abbott Laboratories
2.7.1 Business Overview
2.7.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.8 Becton Dickinson
2.8.1 Business Overview
2.8.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.9 Roche
2.9.1 Business Overview
2.9.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Eppendorf
2.10.1 Business Overview
2.10.2 Latent Tuberculosis Infection (LTBI) Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Latent Tuberculosis Infection (LTBI) Testing Market Competition, by Players
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Latent Tuberculosis Infection (LTBI) Testing Players Market Share
3.2.2 Top 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share
3.3 Market Competition Trend
4 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Regions
4.2 North America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
4.3 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
4.5 South America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
5 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
5.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
5.2 USA Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
5.3 Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
5.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
6 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
6.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
6.2 Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
6.3 UK Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
6.4 France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
6.5 Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
6.6 Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
7.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
7.2 China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
7.3 Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
7.4 Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
7.5 India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
8 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
8.1 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
8.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
8.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
8.4 Colombia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Latent Tuberculosis Infection (LTBI) Testing by Countries
9.1 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
9.3 UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
9.4 Egypt Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
9.6 South Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
10 Global Latent Tuberculosis Infection (LTBI) Testing Market Segment by Type
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Type (2014-2019)
10.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2019-2024)
10.3 Tuberculin Skin Test (TST) Revenue Growth Rate (2014-2024)
10.4 Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Latent Tuberculosis Infection (LTBI) Testing Market Segment by Application
11.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2014-2019)
11.2 Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2019-2024)
11.3 Household Contacts with Pulmonary TB Revenue Growth (2014-2019)
11.4 PLHIV Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2024)
12.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2024)
12.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Regions (2019-2024)
12.3 North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
12.4 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
12.6 South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Latent Tuberculosis Infection (LTBI) Testing Picture
Table Product Specifications of Latent Tuberculosis Infection (LTBI) Testing
Table Global Latent Tuberculosis Infection (LTBI) Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Types in 2018
Figure Tuberculin Skin Test (TST) Picture
Figure Interferon Gamma Released Assay (IGRA) Picture
Figure Others Picture
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Application (2014-2024)
Figure Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Applications in 2018
Figure Household Contacts with Pulmonary TB Picture
Figure PLHIV Picture
Figure Others Picture
Table Global Market Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Danaher Basic Information, Manufacturing Base and Competitors
Table Danaher Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Danaher Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table BioMerieux Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Roche Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Eppendorf Basic Information, Manufacturing Base and Competitors
Table Eppendorf Latent Tuberculosis Infection (LTBI) Testing Type and Applications
Table Eppendorf Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Players (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2017
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2018
Figure Global Top 5 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2018
Figure Global Top 10 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2018
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Regions (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions in 2018
Figure North America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure South America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Table North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
Table North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2018
Figure USA Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2014-2019)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2018
Figure Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure UK Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2018
Figure China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Table South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2014-2019)
Table South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2018
Figure Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Colombia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2018
Figure Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Egypt Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure Nigeria Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Figure South Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Type (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type in 2018
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Type (2019-2024)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2019-2024)
Figure Global Tuberculin Skin Test (TST) Revenue Growth Rate (2014-2019)
Figure Global Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application in 2018
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Application (2019-2024)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2019-2024)
Figure Global Household Contacts with Pulmonary TB Revenue Growth Rate (2014-2019)
Figure Global PLHIV Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
Figure South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2019-2024)

Global Prostate-specific Antigen (PSA) Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2974 2019年12月30日 120Pages
「前立腺特異抗原（PSA）テストの世界市場2019年」は、グローバルにおける前立腺特異抗原（PSA）テスト市場を展望するレポートです。前立腺特異抗原（PSA）テストのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジ...

世界の結核診断および治療市場予測（～2024年）：企業別、地域別、種類・用途別

Global Tuberculosis Diagnostics and Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3589 2019年9月16日 139Pages
本調査レポートは、結核診断および治療の世界市場について調べ、まとめました。種類別セグメントは、皮膚試験、実験室試験等、用途別セグメントは、病院、クリニック、その他等に区分しました。結核診断および治療の世界市場概観、企業動向、企業別結核診断および治療シェア、市場規模推移、市場規模予測（2019年-20...

サイトメガロウイルス（HHV-5）感染症治療薬の世界市場 2019年版：種類別（経口薬、注射）、用途別（病院、診療所、その他）

Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2631 2019年12月30日 120Pages
「サイトメガロウイルス（HHV-5）感染症治療薬の世界市場2019年」は、グローバルにおけるサイトメガロウイルス（HHV-5）感染症治療薬市場を展望するレポートです。サイトメガロウイルス（HHV-5）感染症治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2...

感染防止装置の世界市場 2019年版：種類別（感染予防用品、医療廃棄物処理可能機器、感染予防機器）、用途別（病院、ライフサイエンス産業、臨床検査室、その他）

Global Infection Prevention Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G1126 2019年12月30日 106Pages
「感染防止装置の世界市場2019年」は、グローバルにおける感染防止装置市場を展望するレポートです。感染防止装置のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）デ...

結核診断市場：世界及び中国市場分析・予測（～2024年）

Tuberculosis Diagnostic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT9429 2019年10月1日 135Pages
「結核診断市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における結核診断市場について調査・分析したレポートで、結核診断の世界市場動向、市場規模、主要企業情報などが含まれています。
・結核診断産業の概要
・結核診断の製造技術分析
・主要企業分析：...

世界のグラム陽性菌感染症薬市場予測（～2024年）：企業別、地域別、種類・用途別

Global Gram-positive Bacterial Infection Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3062 2019年9月16日 121Pages
本調査レポートは、グラム陽性菌感染症薬の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、抗真菌剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。グラム陽性菌感染症薬の世界市場概観、企業動向、企業別グラム陽性菌感染症薬シェア、市場規模推移、市場規模...

世界の眼感染症薬市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Eye Infection Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F1034 2019年11月4日 122Pages
本調査レポートは、眼感染症薬の世界市場について調べ、まとめました。種類別セグメントは、レボフロキサシン、シプロフロキサシン、その他等、用途別セグメントは、結膜炎、麦粒腫、まぶたの感染、その他等に区分しました。眼感染症薬の世界市場概観、メーカー動向、メーカー別眼感染症薬シェア、市場規模推移、市場規模予...

世界の細菌性眼感染症治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Bacterial Eye Infection Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0476 2019年11月4日 124Pages
本調査レポートは、細菌性眼感染症治療薬の世界市場について調べ、まとめました。種類別セグメントは、軟膏、目薬、医薬品等、用途別セグメントは、病院薬局、小売薬局、その他等に区分しました。細菌性眼感染症治療薬の世界市場概観、メーカー動向、メーカー別細菌性眼感染症治療薬シェア、市場規模推移、市場規模予測（2...

世界の感染予防市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Infection Prevention Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F1389 2019年11月4日 115Pages
本調査レポートは、感染予防の世界市場について調べ、まとめました。種類別セグメントは、消毒器、滅菌装置、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。感染予防の世界市場概観、メーカー動向、メーカー別感染予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析...

世界の手術および感染制御デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Surgical and Infection Control Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F2388 2019年11月4日 116Pages
本調査レポートは、手術および感染制御デバイスの世界市場について調べ、まとめました。種類別セグメントは、手術器具、感染制御器具等、用途別セグメントは、病院、診療所、その他等に区分しました。手術および感染制御デバイスの世界市場概観、メーカー動向、メーカー別手術および感染制御デバイスシェア、市場規模推移、...

世界の結核診断および治療市場予測（～2024年）：企業別、地域別、種類・用途別 Tuberculosis refer to the infectious bacterial disease characterized by the growth of nodules (tubercles) in the tissues, especially the lungs. Scope of the Report: The global Tuberculosis Diagnostics and Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by…
結核診断市場：世界及び中国市場分析・予測（～2024年） Tuberculosis Diagnostic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Tuberculosis Diagnostic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tuberculosis Diagnosti…
世界のグラム陽性菌感染症薬市場予測（～2024年）：企業別、地域別、種類・用途別 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans. Scope of the Report: The global Gram-positive Bacterial Infection Drugs market is valued at xx million USD in 2018 and is expected to re…
サイトメガロウイルス（HHV-5）感染症治療薬の世界市場 2019年版：種類別（経口薬、注射）、用途別（病院、診療所、その他） Description Scope of the Report: The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in f…
感染制御製品市場：世界及び中国市場分析・予測（～2024年） Infection Control Product Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Infection Control Product industry with a focus on the Chinese market. The report provides key statistics on the market status of the Infection Control …